BACKGROUND Valvular heart disease affects more than 100 million people worldwide and is associated with significant morbidity and mortality.The prevalence of at least moderate valvular heart disease is 2.5%across all ...
Supported by The National Natural Science Foundation of China,No.82171334;The Chongqing Science and Health Joint Medical Research Project,No.2024MSXM155.
BACKGROUND Autologous fat injection in facial reconstruction is a common cosmetic surgery.Although cerebral fat embolism(CFE)as a complication is rare,it carries serious health risks.CASE SUMMARY We present a case of ...
BACKGROUND:Bleeding outcomes are crucial primary safety endpoints in studies involving thrombolytic agents.This study aimed to determine the incidence,characteristics and mortality outcomes of bleeding following ST-el...
To compare the effects of ticagrelor combined with prourokinase and reteplase thrombolysis on cardiac function and blood-related indexes in patients with ST-segment elevation myocardial infarction(STEMI),280 patients ...
supported by National Institute of Health(NIH)grants(R01HL141967 and R21EB027304).
Thromboembolism in blood vessels poses a serious risk of stroke,heart attack,and even sudden death if not properly managed.Sonothrombolysis combined with ultrasound contrast agents has emerged as a promising approach ...
National Key R&D Program of China(2017YFC1308201);Clinical Research Plan of SHDC(SHDC2020CR1041B);Shanghai Municipal Key Clinical Specialty(shslczdzk06102).
Background The performance of intravenous tenecteplase in patients who had an acute ischaemic stroke with large/medium vessel occlusion or severe stenosis in an extended time window remains unknown. We investigated th...
Intravenous thrombolysis is not recommended in anticoagulated patients receiving direct oral anticoagulants(DOACs)and a recent intake within the last 48hours in US and European guidelines.However,three observational s...